HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Albert Jeltsch Selected Research

Proteins (Proteins, Gene)

3/2024Approaching the catalytic mechanism of protein lysine methyltransferases by biochemical and simulation techniques.
10/2023Methylation of the transcription factor E2F1 by SETD6 regulates SETD6 expression via a positive feedback mechanism.
1/2023The T1150A cancer mutant of the protein lysine dimethyltransferase NSD2 can introduce H3K36 trimethylation.
1/2020Analysis of the Substrate Specificity of the SMYD2 Protein Lysine Methyltransferase and Discovery of Novel Non-Histone Substrates.
1/2018The Legionella pneumophila Methyltransferase RomA Methylates Also Non-histone Proteins during Infection.
5/2015Somatic cancer mutations in the DNMT2 tRNA methyltransferase alter its catalytic properties.
1/2015Somatic cancer mutations in the MLL3-SET domain alter the catalytic properties of the enzyme.
12/2014Role of somatic cancer mutations in human protein lysine methyltransferases.
5/2006Mutations in DNA methyltransferase DNMT3B in ICF syndrome affect its regulation by DNMT3L.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Albert Jeltsch Research Topics

Disease

25Neoplasms (Cancer)
03/2024 - 11/2004
3Genomic Instability
11/2012 - 03/2008
2Infections
01/2018 - 10/2003
2Leukemia
01/2017 - 03/2014
2Carcinogenesis
12/2014 - 07/2008
2variable Immunodeficiency syndrome
05/2006 - 06/2004
1Nervous System Diseases (Neurological Disorders)
03/2024
1Cardiovascular Diseases (Cardiovascular Disease)
03/2024
1Prostatic Neoplasms (Prostate Cancer)
02/2024
1Beckwith-Wiedemann Syndrome (Exomphalos Macroglossia Gigantism Syndrome)
01/2024
1Imprinting Disorders
01/2024
1Silver-Russell Syndrome
01/2024
1Pathologic Processes
10/2023
1Autism Spectrum Disorder
12/2021
1Giant Cell Tumor of Bone
10/2020
1Paraganglioma (Paragangliomas)
12/2019
1Virus Diseases (Viral Diseases)
01/2018
1Cognitive Dysfunction
12/2017
1Mental Disorders (Mental Disorder)
01/2017
1Genetic Translocation (Chromosomal Translocation)
12/2014
1Ovarian Neoplasms (Ovarian Cancer)
01/2014
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2012
1alpha-Thalassemia
06/2011
1X-Linked Mental Retardation (Mental Retardation, X Linked)
06/2011
1Conversion Disorder (Astasia Abasia)
01/2009
1Carcinoma (Carcinomatosis)
07/2008
1Decompression Sickness (Bends)
12/2007

Drug/Important Bio-Agent (IBA)

17DNA (Deoxyribonucleic Acid)IBA
01/2024 - 11/2004
13MethyltransferasesIBA
05/2023 - 11/2004
10EnzymesIBA
02/2024 - 11/2004
9Proteins (Proteins, Gene)FDA Link
03/2024 - 05/2006
7Histones (Histone)IBA
12/2021 - 11/2012
5Histone-Lysine N-MethyltransferaseIBA
10/2023 - 11/2012
5Lysine (L-Lysine)FDA Link
01/2023 - 11/2012
2ChromatinIBA
12/2017 - 06/2004
2Epithelial Cell Adhesion MoleculeIBA
01/2014 - 07/2008
2hydrogen sulfite (bisulfite)IBA
01/2009 - 07/2008
1Cadherins (E-Cadherin)IBA
03/2024
1NucleotidesIBA
11/2023
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2020
1LigandsIBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2018
1Cocaine (Cocaine HCl)IBA
12/2017
1Histone MethyltransferasesIBA
01/2017
1Asp Transfer RNAIBA
05/2015
1Transfer RNA (tRNA)IBA
05/2015
1tRNA MethyltransferasesIBA
05/2015
1SGI-1027IBA
03/2014
1DecitabineFDA Link
12/2012
1Azacitidine (5 Azacytidine)FDA Link
12/2012
1CytosineIBA
08/2011
1X-linked Nuclear ProteinIBA
06/2011
1TeaIBA
04/2011
1PolyphenolsIBA
04/2011
1CoffeeFDA Link
04/2011
1Small Interfering RNA (siRNA)IBA
07/2008
1DNA modification methylase SssI (M.SssI)IBA
07/2008
1CytidineIBA
11/2004
1Satellite DNA (Satellite DNAs)IBA
06/2004
1HeterochromatinIBA
06/2004
1DNA Restriction-Modification Enzymes (Restriction Modification Systems)IBA
10/2003

Therapy/Procedure

6Therapeutics
01/2020 - 11/2004